GlassScriptPhysician profile
Natalie Hanson
NPI 1770392193
$1,758.97
in general payments reported to CMS, 2019-2025
19 companies · $1,759 in 2025
The $1,759 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $374.46 | 2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $260.74 | 2025 | Zepbound, Mounjaro, Kisunla |
| Abbvie INC. | $247.04 | 2025 | |
| Corcept Therapeutics | $137.50 | 2025 | Korlym |
| Dexcom, INC. | $118.48 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Pfizer INC. | $109.96 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $90.71 | 2025 | Airsupra, Breztri |
| Lundbeck LLC | $84.73 | 2025 | Rexulti |
| Exact Sciences Corporation | $64.73 | 2025 | The Cologuard Plus Collection Kit |
| Brainsway USA INC | $50.23 | 2025 | Deep Tms |
| Glaxosmithkline, LLC. | $36.43 | 2025 | Trelegy Ellipta, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.88 | 2025 | Xifaxan |
| Sumitomo Pharma America, INC. | $32.27 | 2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $24.71 | 2025 | Gardasil 9, Capvaxive |
| Esperion Therapeutics, INC. | $22.00 | 2025 | Nexletol |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.27 | 2025 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $18.19 | 2025 | Zoryve |
| Tactile Systems Technology INC | $17.74 | 2025 | Nimbl, Flexitouch Plus |
| United Therapeutics Corporation | $14.90 | 2025 | Tyvaso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Hanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.